Related by context. Frequent words. (Click for all words.) 78 gastrointestinal stromal tumors GIST 76 refractory chronic lymphocytic 74 Lenalidomide 73 Dasatinib 72 Meets Primary Endpoint 72 Epratuzumab 72 leukemia ALL 72 Natalizumab 72 Irinotecan 71 Kepivance 71 Myelofibrosis 71 Idiopathic Pulmonary Fibrosis 71 Ischemic 71 leukemia CLL 71 mRCC 71 recurrent glioblastoma 71 Etanercept 71 Combination therapy 71 Chronic Heart Failure 71 Chronic Lymphocytic Leukemia 71 Diabetic Neuropathy 71 unresectable 71 colorectal carcinoma 70 J Am Coll 70 Trastuzumab 70 metastatic renal cell carcinoma 70 voriconazole 70 DOXIL 70 tumor lysis syndrome 70 ankylosing spondylitis AS 70 bleomycin 70 resectable 70 secondary hyperparathyroidism 70 liposomal formulation 70 GISTs 70 Eltrombopag 70 chemoradiotherapy 70 bendamustine 70 pancreatic adenocarcinoma 69 Tacrolimus 69 Vaprisol 69 metastatic castration resistant 69 Oxaliplatin 69 superficial bladder cancer 69 Aliskiren 69 Hydroxyurea 69 severe neutropenia 69 Eculizumab 69 Chronic Hepatitis C 69 pheochromocytoma 69 Alemtuzumab 69 HER2 positive metastatic breast 69 Pivotal Phase III 69 Epidermal Growth Factor Receptor 69 relapsing multiple sclerosis 69 Renal Cell Carcinoma 69 malignant pleural mesothelioma 69 multiple myeloma MM 69 efalizumab 69 relapsed refractory 69 Lubiprostone 69 mTOR inhibitor 69 Receives Orphan Drug Designation 69 rFVIIa 69 pertuzumab 69 trimethoprim sulfamethoxazole 68 Amrubicin 68 mycophenolate mofetil 68 Capecitabine 68 luteinizing hormone releasing 68 candidemia 68 Single Dose 68 Metastases 68 Proxinium TM 68 Benign Prostatic Hyperplasia 68 TTR amyloidosis 68 murine model 68 Factor VIIa 68 Cyclophosphamide 68 interferon alfa 2b 68 mesylate 68 gastrointestinal stromal tumors 68 Bortezomib 68 Recombinant Human 68 breast carcinoma 68 Systemic Lupus Erythematosus 68 myeloproliferative disorders 68 epirubicin 68 cidofovir 68 Carotid 68 Denufosol 68 Thrombocytopenia 68 myelodysplastic syndrome MDS 68 Dermatol 68 Erlotinib 68 hyperparathyroidism 68 idebenone 68 active ankylosing spondylitis 68 T#I [002] 68 Bevacizumab 68 goserelin